Smart Risks. Bold Science.
Our Approach to Partnering
Scientific Areas of Interest
As a community of scientists, we appreciate the brilliance and dedication required to uncover the next potential medical breakthroughs. We take seriously our responsibility as partners in stewarding your idea to success.
Kenneth Custer, Ph.D.Head of Business Development
180+
Actively managed alliances
15/20
of Lilly’s last new launches enabled by external innovation
2B+
committed to biotech over the last 20 years through venture investing
Find Lilly at Upcoming Events
Lilly in the News
Lilly and ProQR to Expand RNA Editing Collaboration
December 22, 2022
Lilly Completes Acquisition of Akouos Expanding Efforts to Help People with Genetic Diseases
December 1, 2022
Lilly and Akouos Announce Expiration of Akouos Tender Offer
November 30, 2022
Lilly to Acquire Akouos to Discover and Develop Treatments for Hearing Loss
October 18, 2022
January 6, 2022
